Pharmaceutical Technology-10-02-2004

Pharmaceutical Technology

A Novel Freeze Pelletization Technique for Preparing Matix Pellets

October 02, 2004

Articles

28

10

Freeze pelletization is a new and simple technique for producing spherical pellets for pharmaceutical use.

Aseptic Processing: A Review of Current Industry Practice

October 02, 2004

Articles

28

10

The authors review current industry practices and regulatory expectations for the aseptic processing of sterile drugs. They compare and outline critical issues in current manufacturing technology and capabilities with regulatory requirements.

Can Inserts Be Improved?

October 02, 2004

Articles

28

10

Stakeholders consider ways to improve printed patient inserts.

Analysis of a Kneading Process to Evaluate Drug Substance-Cyclodextrin Complexation

October 02, 2004

Articles

28

10

Using dimensionless analytical models, the authors establish the relationships among the essential parameters of a kneading complexation process.

Drug Development Linked More Closely to Diagnostics

October 02, 2004

Articles

28

10

FDA and industry discuss proposals for regulating combination diagnostics, medical devices, and pharmacogenomic-based drug products.

Preparation and In Vitro Characterization of Self-Nanoemulsified Drug Delivery Systems of Coenzyme Q10 Using Chiral Essential Oil Components

October 02, 2004

Articles

28

10

By enhancing stability and in vitro drug-release characteristics, limonene enantiomers are a natural-source alternative for developing and characterizing self-nanoemulsified drug delivery systems.

In The Spotlight-October 2004

October 02, 2004

Articles

28

10

Pharmaceutical Science & Technology Innovations

October 2004

October 02, 2004

Articles

28

10

Pharmaceutical Science & Technology News

Visible-Residue Limit for Cleaning Validation and its Potential Application in Pharmaceutical Research Facility

October 02, 2004

Articles

28

10

Evaluations have shown, in most cases, visual observations are sensitive enough to verify equipment cleanliness. An experiment was conducted to explore the possibility of using a visible-residue limit as an acceptable cleaning limit in a pharmaceutical research facility, including an evaluation of the limits and subjectivity of ?visually clean? equipment.

The High Price of Success

October 02, 2004

Articles

28

10

Beyond the inevitable debate over profit margins, the increasing range and effectiveness of modern medicine leave us with one core issue: the high price of success.

Pharma Company Investment in Parenteral Manufacturing Capacity Picking Up

October 02, 2004

Articles

28

10

Big Pharma is ramping up capital spending in parenteral manufacturing at the same time that contract manufacturers are completing their own major investment programs.

USP General Notices and General Test Chapters: Interpretations and Misinterpretations

October 02, 2004

Articles

28

10

The authors dispel common misinterpretations of the United States Pharmacopeia.

Breaking the Barrier: Advances in Transdermal Technology

October 02, 2004

Articles

28

10

Transdermal drug technology specialists are meeting demands for methods that can painlessly deliver larger molecules in therapeutic quantities.